Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Myriad Genetics Inc (NQ: MYGN)
22.49 USD  -0.56 (-2.43%)
Official Closing Price  /  Updated: 6:50 PM EDT, Aug 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,107,200
Open 23.02
Bid (Size) 22.05 (10)
Ask (Size) 23.50 (10)
Prev. Close 23.05
Today's Range 22.32 - 23.61
52wk Range 22.07 - 50.44
Shares Outstanding 69,906,818
Dividend Yield N/A
Performance
YTD
-22.45%
-22.45%
1 Month
-22.26%
-22.26%
3 Month
-4.09%
-4.09%
6 Month
-29.25%
-29.25%
1 Year
-54.38%
-54.38%
Top News
More News
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
from GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. (NASDAQ: MYGN) on Behalf of Stockholders and Encourages Myriad Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against Myriad Genetics, Inc. (NASDAQ: MYGN) on behalf of Myriad investors. Our investigation concerns whether Myriad has violated the... Read More
from PR Newswire
More News
Read More
Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention
from GlobeNewswire News Releases
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
from GlobeNewswire News Releases
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
from Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN
from GlobeNewswire News Releases
Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations, Investors With Losses Should Contact Firm
from PR Newswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
from Business Wire News Releases
SHAREHOLDER ALERT: Investigation of Myriad Genetics Announced by Holzer & Holzer, LLC
from Business Wire News Releases
Investor Alert: Kaplan Fox Investigates Myriad Genetics, Inc.
from PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Myriad Genetics, Inc. – MYGN
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.